JG26, CAS [[1464910-32-4]]

Produktübersicht

• Artikelname: JG26, CAS [[1464910-32-4]]
• Artikelnummer: MCE-HY-120852
• Hersteller Artikelnummer: HY-120852
• Alternativnummer: MCE-HY-120852-50MG,MCE-HY-120852-10MMX1ML,MCE-HY-120852-1MG,MCE-HY-120852-25MG,MCE-HY-120852-5MG,MCE-HY-120852-10MG,MCE-HY-120852-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

JG26 is an ADAM inhibitor with IC50 values of 12 nM, 1.9 nM, and 150 nM for ADAM8, ADAM17, and ADAM10, respectively. JG26 inhibits MMP-12 with an IC50 value of 9.4 nM. JG26 inhibits AngII (HY-13948)-induced EGFR transactivation and ERK activation. JG26 increases the expression of ACE2, inhibits the cleavage of CD23, reduces the infection of SARS-CoV-2. JG26 inhibits colorectal cancer metastasis. JG26 can be used for research on Hodgkin lymphoma and vascular diseases[1][2][3][4][5][6].

Produkteigenschaften

• Molekulargewicht: 594.27
• Reinheit: 98.14
• CAS Nummer: [1464910-32-4]
• Formel: C19H22Br2N4O6S
• Target-Kategorie: Angiotensin-converting Enzyme (ACE),EGFR,ERK,MMP,SARS-CoV

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound